BioRestorative Therapies Named One of Ten Most Innovative Regenerative Medicine Companies in 2022 by Insights Care Magazine
26 janv. 2022 06h00 HE
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Jan. 26, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company" or “BioRestorative”) (NASDAQ:BRTX), a life sciences company focused on adult stem cell-based...
BioRestorative Therapies, Inc. Releases Year-End Message
20 déc. 2021 06h00 HE
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Dec. 20, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company" or “BioRestorative”) (NASDAQ:BRTX), a life sciences company focused on adult stem cell-based...
North America $1.4 Billion Organoids Market to 2027 - Emergence of Three-dimensional (3-D) Organoids
16 mars 2021 05h28 HE
|
Research and Markets
Dublin, March 16, 2021 (GLOBE NEWSWIRE) -- The "North America Organoids Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type, Application, and Source, and Country" report has been...
Global Organoids Market Report 2021: Increasing Adoption of Personalized Drugs to Drive Organoids Market - Forecast to 2027
16 mars 2021 05h23 HE
|
Research and Markets
Dublin, March 16, 2021 (GLOBE NEWSWIRE) -- The "Organoids Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type; Application; Source, and Geography" report has been added to...
India $470 Million Stem Cell Market Competition Forecast & Opportunities, 2021-2026
16 févr. 2021 04h18 HE
|
Research and Markets
Dublin, Feb. 16, 2021 (GLOBE NEWSWIRE) -- The "India Stem Cell Market, By Product Type (Adult; Induced Pluripotent; Human Embryonic; Others), By Application (Regenerative Medicine Vs. Drug Discovery...
Global Mesenchymal Stem Cells (MSC) Market Strategic Report 2021: Profiles & Activities of the Leading 98 MSC Companies
11 févr. 2021 05h23 HE
|
Research and Markets
Dublin, Feb. 11, 2021 (GLOBE NEWSWIRE) -- The "Mesenchymal Stem Cells - Advances and Applications, 2021" report has been added to ResearchAndMarkets.com's offering. Mesenchymal stem cells (MSCs)...
India Stem Cell Markets, Competition Forecast & Opportunities, 2026
24 nov. 2020 04h53 HE
|
Research and Markets
Dublin, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The "India Stem Cell Market by Product Type (Adult; Induced Pluripotent; Human Embryonic; Others), by Application (Regenerative Medicine Vs. Drug Discovery...
Mesoblast Reports 2015 Financial Year Results And Provides Update On Phase 3 Chronic Heart Failure Program
16 août 2015 20h28 HE
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Aug. 16, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX: MSB; USOTC: MBLTY) today reported its 2015 full financial year results, and provided an update on important...
American CryoStem Enters Into Definitive Term Sheet With Health Innovative Technology Corporation Limited
02 juil. 2014 08h30 HE
|
American CryoStem Corp.
EATONTOWN, N.J., July 2, 2014 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...
American CryoStem Announces Agreement With the nanoRANCH Division of UHV Technologies for Cancer Research Utilizing ATCELL(TM)
18 juin 2014 09h00 HE
|
American CryoStem Corp.
EATONTOWN, N.J., June 18, 2014 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...